Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Aug. 04, 2024	Jul. 30, 2023
OPERATING ACTIVITIES
Net income	$ 309.4	$ 230.2
Adjustments to reconcile to net cash provided by operating activities:
Depreciation and amortization	141.9	147.8
Equity in net income of unconsolidated affiliates	(24.1)	(21.1)
Deferred taxes	(7.3)	(22.1)
Stock-based compensation expense	26.9	27.4
Other gain	(10.0)	0.0
Changes in operating assets and liabilities:
Trade receivables, net	(91.4)	36.2
Other receivables	3.5	0.9
Inventories, net	(155.3)	1.2
Accounts payable, accrued expenses and deferred revenue	37.5	(153.0)
Prepaid expenses	4.0	(45.9)
Other, net	(9.4)	(5.4)
Net cash provided by operating activities	225.7	196.2
INVESTING ACTIVITIES
Purchases of property, plant and equipment	(75.4)	(115.9)
Proceeds from sale of Warner's, Olga and True&Co. women's intimates businesses	2.5	0.0
Purchases of investments held in rabbi trust	(3.0)	(2.4)
Proceeds from investments held in rabbi trust	0.4	0.9
Proceeds from cross-currency swap contracts (net investment hedges)	3.5	0.0
Net cash used by investing activities	(72.0)	(117.4)
FINANCING ACTIVITIES
Net proceeds from (payments on) from short-term borrowings	8.3	(28.8)
Repayment of 2022 facilities	(5.9)	(6.0)
Net proceeds from settlement of awards under stock plans	7.3	0.1
Proceeds from 4 1/8% senior notes, net of related fees	553.1	0.0
Redemption of 3 5/8% senior notes	(561.7)	0.0
Cash dividends	(4.3)	(4.8)
Acquisition of treasury shares	(245.4)	(214.2)
Payments of finance lease liabilities	(2.2)	(2.5)
Net cash used by financing activities	(250.8)	(256.2)
Effect of exchange rate on cash and cash equivalents	(0.5)	(0.5)
Decrease in cash and cash equivalents	(97.6)	(177.9)
Cash and cash equivalents at beginning of period	707.6	550.7
Cash and cash equivalents at end of period	$ 610.0	$ 372.8